Home › Colon Cancer › West Virginia › Morgantown
Colon Cancer clinical trials in Morgantown, WV
5 studies for Colon Cancer are looking for participants at sites in and around Morgantown (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
RecruitingPhase 3
- West Virginia University ( Site 2017), Morgantown
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RecruitingPhase 3
- West Virginia University Cancer Institute, Morgantown
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Recruiting
- West Virginia University Healthcare, Morgantown
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RecruitingPhase 2/3
- West Virginia University Healthcare, Morgantown
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Morgantown
Colon Cancer trials in other cities
- Boston, MA22 studies
- New York City, NY22 studies
- Houston, TX20 studies
- Los Angeles, CA16 studies
- Nashville, TN16 studies
- St. Louis, MO15 studies
- Arlington, VA15 studies
- Chicago, IL14 studies
- San Antonio, TX14 studies
- Baldwin Park, CA14 studies
- Baltimore, MD13 studies
- Tampa, FL13 studies
Other studies in Morgantown
- Breast Cancer10 studies
- Ovarian Cancer10 studies
- Non-Small Cell Lung Cancer10 studies
- Cardiovascular Disease8 studies
- Heart Failure6 studies
- Metastatic Cancer6 studies
- Cancer (all types)6 studies
- Lung Cancer6 studies
- Melanoma5 studies
- Migraine5 studies
- Stroke4 studies
- Pancreatic Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.